67 research outputs found

    The interaction of bacteria with the respiratory mucosa in vitro and in vivo

    Get PDF
    Using a simple nasopharyngeal organ culture in which the mucosa is exposed to air, this thesis describes the interaction between two piliated and one non-piliated variants of Neisseria meningitidis and the interaction of a pneumolysin sufficient and deficient isogenic variant of Streptococcus pneumoniae with respiratory mucosa. Piliated N. meningitidis adhered more often than the non-piliated variant to the respiratory mucosa and demonstrated tropism for non-ciliated epithelial cells and only rarely adhered to mucus. In contrast, S.pneumoniae demonstrated tropism for mucus. Infection resulted in a change in the appearance of mucus, ciliary beat slowing and epithelial damage. To assess if other bacteria may impair mucociliary clearance by disorganising cilia the effect of pyocyanin, 1-hydroxyphenazine (1-HP) and rhamnolipid on the orientation of human ciliated cells was studied. Pyocyanin and 1-HP at pathophysiological concentrations caused ciliary slowing, dyskinesia and disorientation of the ciliary microtubular pairs. However, the orientation of basal feet did not change. Rhamnolipid at pathophysiologic concentrations caused ciliary slowing but neither dyskinesia or disorientation. Disorientation of ciliary beat as well as slowed CBF may contribute to the slowing of mucociliary clearance in vivo. To assess if ciliary disorientation occurs as an acquired and/or congenital abnormality, groups of patients with chronic upper respiratory tract inflammation due to infection and patients with the clinical features of primary ciliary dyskinesia but normal ciliary beat frequency and ciliary ultrastructure were studied. Ciliary disorientation was associated with slowing of nasomucociliary clearance. The clinical features, ciliary function studies and the ciliary orientation of eleven patients with the classical features of primary ciliary dyskinesia but with normal ciliary ultrastructure were assessed. The results suggests that ciliary disorientation alone does represent a new variant of primary ciliary dyskinesia

    Novel Gene Discovery in Primary Ciliary Dyskinesia

    Get PDF
    Primary Ciliary Dyskinesia (PCD) is one of the ‘ciliopathies’, genetic disorders affecting either cilia structure or function. PCD is a rare recessive disease caused by defective motile cilia. Affected individuals manifest with neonatal respiratory distress, chronic wet cough, upper respiratory tract problems, progressive lung disease resulting in bronchiectasis, laterality problems including heart defects and adult infertility. Early diagnosis and management are essential for better respiratory disease prognosis. PCD is a highly genetically heterogeneous disorder with causal mutations identified in 36 genes that account for the disease in about 70% of PCD cases, suggesting that additional genes remain to be discovered. Targeted next generation sequencing was used for genetic screening of a cohort of patients with confirmed or suggestive PCD diagnosis. The use of multi-gene panel sequencing yielded a high diagnostic output (> 70%) with mutations identified in known PCD genes. Over half of these mutations were novel alleles, expanding the mutation spectrum in PCD genes. The inclusion of patients from various ethnic backgrounds revealed a striking impact of ethnicity on the composition of disease alleles uncovering a significant genetic stratification of PCD in different populations. Pathogenic mutations were also identified in several new candidate genes not previously linked to PCD. Molecular and cell biology techniques were coupled with model organism studies to characterize the involvement of the new candidate genes in cilia motility and PCD. Paramecium was proven to be a good model for functional characterization of PCD potential candidate genes. The previously uncharacterized C11orf70 was identified to play a highly conserved role in dynein assembly and intraflagellar transport (IFT)-related cilia cargo trafficking. Mutations identified in DNAH9 resulted in a distinct motile cilia defect with mild respiratory symptoms, unusual in PCD. Mutations identified in two intraflagellar transport genes, IFT74 and WDR19, linked together primary and motile ciliopathy phenotypes observed in the affected individuals

    Rare Respiratory Diseases: A Personal and a Public Health Problem

    Get PDF
    Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare diseases are, in general, chronic, debilitating diseases, which in many cases threaten patients’ lives. It is estimated that 1–2 million people in the European Union are affected by a rare respiratory disease, which is a public health problem. Due to the low prevalence and severity of many of these diseases, whose symptoms often initially manifest in childhood, combined efforts are needed to improve our knowledge of the pathophysiology of these diseases that will lead to the development of new, more effective treatments. Therefore, since rare respiratory diseases represent an important field in medicine, we propose this Special Issue to promote the dissemination of the latest advances in basic and clinical research in these diseases. Prof. Dr. Francisco Dasí Guest Edito

    Non-typeable Haemophilus influenzae and rhinovirus co-infection of the respiratory epithelium

    Get PDF
    Non-typeable Haemophilus influenzae (NTHi) and rhinovirus 16 (RV16) are strongly associated with symptomatic disease in healthy individuals and with disease exacerbations in patients with chronic lung conditions such as chronic obstructive pulmonary disease (COPD). Co-infection with RV16 and NTHi is thought to cause more severe exacerbations, although the mechanism behind this remains unknown. The hypothesis of this project was that RV16 and NTHi co-infection of the respiratory epithelium results in increased bacterial growth, greater epithelial damage and inflammation compared to single NTHi infection. To investigate this, healthy and COPD primary respiratory epithelial cells cultured at air-liquid interface for 6 days (pre-ciliation) or 28 days (ciliated) were infected with RV16 and 24 hours later challenged with NTHi. // In healthy and COPD ciliated epithelial cultures, NTHi bound to motile cilia within minutes, then formed filamentous morphotypes and biofilm-like aggregates which reduced ciliary beat amplitude by 24 hours post infection. NTHi epithelial invasion occurred preferentially in non-ciliated epithelial cells suggesting that ciliation may protect against NTHi invasion. This might be of importance in COPD cultures, where the number of ciliated cells was reduced, reflecting what is seen in vivo. // Co-infection of ciliated cultures with RV16 and NTHi resulted in a reduced ciliary beat frequency, epithelial barrier dysfunction and a more complex inflammatory response from healthy and COPD ciliated cultures, compared to NTHi single infection. RV16 co-infection also promoted mucin gene expression and enhanced NTHi growth by altering epithelial cell apical fluid secretion. In contrast, pre-ciliation cultures showed markedly reduced responses to single RV16 or NTHi infection and their co-infection compared to ciliated cultures. However, pre-ciliation cultures were susceptible to NTHi invasion and promoted NTHi growth during co-infection with RV16, suggesting they may act like a niche for bacterial colonisation. // In conclusion, this study has shown that NTHi infection is able to affect ciliary function, form biofilm and invade the epithelium without epithelial barrier damage or induction of a complex inflammatory response, suggestive of a colonizer behaviour. In contrast, co-infection with RV16 and NTHi led to NTHi growth, a goblet cell-specific transcriptional profile, impaired ciliary function and epithelial barrier and increased inflammation which could result in increased bacterial dissemination and COPD exacerbation

    Diagnostic tools in Rhinology EAACI position paper

    Get PDF
    This EAACI Task Force document aims at providing the readers with a comprehensive and complete overview of the currently available tools for diagnosis of nasal and sino-nasal disease. We have tried to logically order the different important issues related to history taking, clinical examination and additional investigative tools for evaluation of the severity of sinonasal disease into a consensus document. A panel of European experts in the field of Rhinology has contributed to this consensus document on Diagnostic Tools in Rhinology

    Primary ciliary dyskinesia: a biopsychosocial approach

    Get PDF
    Background: Primary ciliary dyskinesia (PCD) is a rare heterogeneous genetic disorder associated with abnormal ciliary structure and function and characterised by progressive sinopulmonary disease. There is no ‘gold standard’ for diagnosing PCD. This thesis aimed: to provide an overview of the PCD patient’s experience, to address some of the complexities in referring and diagnosing PCD patients, and to provide PCD-specific validated health-related quality of life (HRQoL) measures. Method: A patient survey to capture patient experience of diagnostic testing was completed in 25 countries and was followed by semi-structured interviews, analysed thematically. Through the analysis of data from consecutive patients referred to a PCD diagnostic centre (2007-2013), sensitivity and specificity were calculated. Patient clinical characteristics were correlated with diagnostic outcome. Using logistic regression, the predictive performance of the best model was simplified into a tool (PICADAR), predicting the likelihood of referrals having PCD. A PCD-specific HRQoL measure (QOL-PCD) was developed following a literature review, expert panel meeting, and semi-structured interviews (n=21). Validation followed with patients completing QOL-PCD and generic HRQoL measures. Results: PCD was found to have a negative impact on physical, emotional, and social functioning, highlighting need for PCD-specific HRQoL measures. Outcome data for diagnostic testing showed that none of the diagnostic testing strategies were 100% accurate. PICADAR has been shown to have good accuracy and validity to predict diagnostic outcome. The QOL-PCD HRQoL demonstrated good internal consistency, test-retest reliability, convergent and divergent validity. Discussion: Findings from the international survey were used to advise on ERS Task Force guidelines for diagnosing PCD. The development of PICADAR will lead to earlier referral of patients. The development of QOL-PCD provides the first disease-specific measure to allow for the assessment of treatments. Overall this thesis has led to advances in the field of PCD; from diagnosis to the treatment and management of patients
    • …
    corecore